APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on APELLIS PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) APELLIS PHARMACEUTICALS, INC.
Analyst Recommendations on APELLIS PHARMACEUTICALS, INC.
05/24Goldman Sachs Adjusts Apellis Pharmaceuticals' Price Target to $84 from $94, Keeps Buy Rat..
MT
05/20Credit Suisse Raises Apellis Pharmaceuticals' Price Target to $49 from $44, Maintains Neut..
MT
05/05Raymond James Adjusts Apellis Pharmaceuticals' Price Target to $102 from $114, Keeps Stron..
MT
05/05Credit Suisse Raises Apellis Pharmaceuticals' PT to $44 from $40, Says On Track to Submit ..
MT
05/05Wedbush Lifts Apellis Pharmaceuticals' Price Target to $40 From $39, Maintains Neutral Rat..
MT
04/28Wedbush Lifts Price Target on Apellis Pharmaceuticals to $39 From $34, Maintains Neutral R..
MT
04/22Oppenheimer Adjusts Apellis Pharmaceuticals Price Target to $68 From $65, Maintains Outper..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 41,95 $
Average target price 71,73 $
Spread / Average Target 71,0%
High Price Target 102,00 $
Spread / Highest target 143%
Low Price Target 40,00 $
Spread / Lowest Target -4,65%
Consensus detail
Consensus revision (last 18 months)